The Part D premium stabilization rule should be made permanent

The rule capping Part D premium increases should continue beyond 2026 to protect seniors from sudden price hikes.

Overview Debates Related claims Topics Sources

Younger patients should receive priority when lifesaving treatment is scarce

Insurers should be barred from setting premiums using genetic tests

Publicly funded healthcare should cover infertility treatment

Medicare for All is a viable solution to the U.S. healthcare crisis

Medicare coverage of anti-obesity drugs would add about $35 billion to federal spending from 2026 to 2034

Semaglutide carries a regulator-confirmed risk of NAION, a very rare optic nerve condition

Semaglutide and tirzepatide are cost-effective for obesity at current net prices

Most adults with obesity but without diabetes stop GLP-1 drugs within a year

Medicare coverage of weight-loss drugs could save Medicare $175–245 billion over ten years

Governments should license publicly funded drug patents to competitors when prices are unaffordable

Healthcare should be free for everyone

Transgender women are women

Public funding should prioritize access to established fertility treatment over enhancement

Healthcare costs will be the deciding issue in the 2026 midterm elections

The ACA enrollment removal process lacks adequate due process protections

Tying Medicare drug prices to international benchmarks will lower patient costs without reducing access to treatments

The finalized international pricing model covers too few drugs to meaningfully reduce Medicare spending

The federal government should impose work requirements on Medicaid beneficiaries

Countries should presume consent to organ donation unless a person opts out

Voters are more likely to attribute fraud in Medicaid and Medicare to providers than to patients